Questions and Answers on Adstiladrin | Gene Therapy for BCG Unresponsive NMIBC
29:46
Introduction to Adstiladrin | Gene Therapy for BCG Unresponsive NMIBC
3:53
Nadofaragene Firadenovec for BCG-Unresponsive NMIBC: 5-Year Follow-Up
26:20
Management of Non-Muscle Invasive Bladder Cancer
1:20:09
Advancements in Bladder Cancer Research: A Conversation with Leading Experts
1:01:01
Journey to Survivorship: Insights from Bladder Cancer Survivors and Advocates
34:34
ZenOnco.io Cancer Healing Journey Sessions | Taha Ahmed | Testicular Cancer Survivor
21:44
Webinar | Movement: A Tool to Optimize Your Bladder Cancer Journey - Part 1 of 4
11:48